Search results
AstraZeneca (LON:AZN) Rating Reiterated by JPMorgan Chase & Co.
ETF DAILY NEWS· 3 days agoAstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research report issued to ...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
AstraZeneca shares rise as pharma group unveils 2030 revenue target By Investing.com
Investing.com· 4 days agoU.K.-listed shares in AstraZeneca (LON:AZN) rose in morning trading on Tuesday after the...
...Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal...
The Woonsocket Call· 3 days agoNona is eligible to receive an additional US$10 million in potential near-term milestone payments and up to US...
AstraZeneca aims for $80 bln in total revenue by 2030
Reuters· 5 days ago, opens new tab aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday,...
AstraZeneca joins obesity biotech SixPeaks at basecamp with $80M for buyout option
FierceBiotech· 3 days agoThe obesity business is cutthroat these days. AstraZeneca is taking no chances on missing out on the...
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
FOX 23 News Albany· 6 days agoAmgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe ...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 4 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves.
AstraZeneca earmarks $1.5B for end-to-end ADC factory in Singapore
Endpoints News· 5 days agoAstraZeneca said on Monday morning it is building a new antibody-drug conjugate facility in...
AstraZeneca Targets $80B Revenue by 2030 Through Pipeline Expansion
Market Watch· 5 days agoBy Helena Smolak AstraZeneca has set out a target to grow revenue to $80 billion by 2030 as it aims to bolster its investment in technologies and platforms....